Pulmatrix Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Pulmatrix
PULM Stock  USD 2.42  0.02  0.82%   
Pulmatrix's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pulmatrix's valuation are provided below:
Gross Profit
-7.2 M
Market Capitalization
8.8 M
Enterprise Value Revenue
22.4001
Revenue
3 K
Earnings Share
(1.71)
There are over one hundred nineteen available trending fundamental ratios for Pulmatrix, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check out Pulmatrix's recent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 19th of February 2026, Enterprise Value is likely to grow to about 15.1 M, while Market Cap is likely to drop about 22.1 M.

Pulmatrix Total Revenue

9.43 Million

Check Pulmatrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pulmatrix's main balance sheet or income statement drivers, such as Interest Expense of 197.6 K, Other Operating Expenses of 19 M or Research Development of 11.1 M, as well as many indicators such as Price To Sales Ratio of 3.57, Dividend Yield of 0.13 or PTB Ratio of 3.11. Pulmatrix financial statements analysis is a perfect complement when working with Pulmatrix Valuation or Volatility modules.
  
Build AI portfolio with Pulmatrix Stock
Check out the analysis of Pulmatrix Correlation against competitors.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.

Pulmatrix Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Accounts Payable847.6 K930.4 K710.1 K
Slightly volatile
Common Stock Shares Outstanding4.4 M4.2 M1.5 M
Slightly volatile
Other Current Assets497.8 K458.9 K429.2 K
Slightly volatile
Total Assets10.9 M11.4 M21.4 M
Slightly volatile
Short and Long Term Debt Total7.8 M7.9 M12.8 M
Slightly volatile
Total Current Liabilities1 M1.1 M3.6 M
Pretty Stable
Cash19.8 M10.9 M15.6 M
Slightly volatile
Non Current Assets Total19.7 K20.7 K5.3 M
Very volatile
Non Currrent Assets Other14.2 K14.9 K243.2 K
Pretty Stable
Cash And Short Term Investments19.8 M10.9 M15.6 M
Slightly volatile
Common Stock Total Equity4.374.6562
Pretty Stable
Liabilities And Stockholders Equity10.9 M11.4 M21.4 M
Slightly volatile
Non Current Liabilities Total73.2 K77 K4.1 M
Very volatile
Total Liabilities1.1 M1.1 M6.6 M
Slightly volatile
Total Current Assets21.3 M11.4 M16.7 M
Slightly volatile
Common Stock4.8 K4.6 K2.3 K
Slightly volatile
Other Assets1.091.15341.4 K
Very volatile
Capital Surpluse191.7 M296.2 M165.9 M
Slightly volatile
Short and Long Term Debt2.8 M2.9 M13.7 M
Slightly volatile
Property Plant Equipment991.8 K1.1 M747.7 K
Slightly volatile
Other Liabilities4.4 M5.5 M4.1 M
Slightly volatile
Long Term Debt Total3.6 M2.9 M4.1 M
Slightly volatile
Net Invested Capital9.8 M10.3 M16.3 M
Pretty Stable
Non Current Liabilities Other486.4 K547.2 K597.3 K
Slightly volatile

Pulmatrix Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses19 M20.2 M16.6 M
Slightly volatile
Research Development11.1 M8.2 M9.4 M
Slightly volatile
Total Operating Expenses12.4 M12 M10.7 M
Slightly volatile
Depreciation And Amortization115.8 K121.9 K291 K
Very volatile
Selling General Administrative6.7 M9 M5.6 M
Slightly volatile
Total Revenue9.4 M9 M4.1 M
Slightly volatile
Cost Of Revenue10.5 M8.2 M9.8 M
Pretty Stable
Non Recurring9.6 M8.4 M7.9 M
Very volatile
Interest Income555.8 K420.3 K1.4 M
Slightly volatile
Selling And Marketing Expenses1.1 M1.2 M3.5 M
Slightly volatile
Reconciled Depreciation984.1 K500.2 K609.6 K
Slightly volatile

Pulmatrix Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation436.9 K459.9 K1.8 M
Pretty Stable
Depreciation661.2 K500.2 K569.4 K
Slightly volatile
Other Non Cash Items3.1 M2.4 M4.3 M
Pretty Stable
End Period Cash Flow20.2 M11 M15.9 M
Slightly volatile
Begin Period Cash Flow18.2 M23.7 M14.2 M
Slightly volatile
Change To Netincome952.5 K1 M3.5 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.573.7629.48
Slightly volatile
Dividend Yield0.130.140.1536
Slightly volatile
Days Sales Outstanding96.4253.37115
Slightly volatile
Book Value Per Share2.682.82164
Slightly volatile
Stock Based Compensation To Revenue0.07150.07532.9428
Pretty Stable
Capex To Depreciation0.531.050.5381
Very volatile
Inventory Turnover95.38107117
Slightly volatile
Days Of Inventory On Hand2.452.763.008
Slightly volatile
Payables Turnover15.3610.1911.9098
Slightly volatile
Sales General And Administrative To Revenue1.091.156.3838
Very volatile
Research And Ddevelopement To Revenue1.01.0613.7187
Slightly volatile
Capex To Revenue0.05570.05860.138
Slightly volatile
Cash Per Share2.853.095.5718
Slightly volatile
Days Payables Outstanding34.0847.3938.6438
Slightly volatile
Intangibles To Total Assets0.10.110.3524
Slightly volatile
Current Ratio10.099.616.2255
Slightly volatile
Receivables Turnover6.727.0816.7112
Pretty Stable
Shareholders Equity Per Share2.682.82164
Slightly volatile
Debt To Equity0.530.56104
Slightly volatile
Capex Per Share0.120.131.6743
Slightly volatile
Revenue Per Share2.332.4616.0676
Slightly volatile
Interest Debt Per Share2.622.76383
Slightly volatile
Debt To Assets0.280.333.2708
Slightly volatile
Operating Cycle96.8353.37116
Slightly volatile
Days Of Payables Outstanding34.0847.3938.6438
Slightly volatile
Ebt Per Ebit1.391.131.3383
Slightly volatile
Effective Tax Rate0.07690.08650.0944
Slightly volatile
Company Equity Multiplier1.91.281.8432
Slightly volatile
Long Term Debt To Capitalization0.170.240.2188
Slightly volatile
Total Debt To Capitalization0.340.380.4059
Slightly volatile
Debt Equity Ratio0.530.56104
Slightly volatile
Quick Ratio10.099.616.219
Slightly volatile
Net Income Per E B T0.720.810.8876
Slightly volatile
Cash Ratio9.689.225.9908
Pretty Stable
Days Of Inventory Outstanding2.452.763.008
Slightly volatile
Days Of Sales Outstanding96.4253.37115
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.191.0353
Slightly volatile
Fixed Asset Turnover0.70.7330.8172
Slightly volatile
Debt Ratio0.280.333.2708
Slightly volatile
Price Sales Ratio3.573.7629.48
Slightly volatile
Asset Turnover0.580.90.9798
Slightly volatile

Pulmatrix Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap22.1 M29.3 M29.1 M
Slightly volatile

Pulmatrix Fundamental Market Drivers

Pulmatrix Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pulmatrix Financial Statements

Pulmatrix investors utilize fundamental indicators, such as revenue or net income, to predict how Pulmatrix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue710.7 K746.2 K
Total Revenue9 M9.4 M
Cost Of Revenue8.2 M10.5 M
Stock Based Compensation To Revenue 0.08  0.07 
Sales General And Administrative To Revenue 1.15  1.09 
Research And Ddevelopement To Revenue 1.06  1.00 
Capex To Revenue 0.06  0.06 
Revenue Per Share 2.46  2.33 
Ebit Per Revenue(1.13)(1.18)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Pulmatrix is a strong investment it is important to analyze Pulmatrix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmatrix's future performance. For an informed investment choice regarding Pulmatrix Stock, refer to the following important reports:
How To Invest In Pulmatrix
Details
Is Pulmatrix Stock a good investment?
Details
What is Pulmatrix's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Pulmatrix Correlation against competitors.
To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Will Pharmaceuticals sector continue expanding? Could Pulmatrix diversify its offerings? Factors like these will boost the valuation of Pulmatrix. Anticipated expansion of Pulmatrix directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Pulmatrix data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(1.71)
Revenue Per Share
0.001
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.47)
Return On Equity
(0.79)
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
It's important to distinguish between Pulmatrix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulmatrix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pulmatrix's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY